Related Experiment Video

Updated: Jun 23, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.1K

Interferon regulatory factor 4 modulates epigenetic silencing and cancer-critical pathways in melanoma cells

Ulduz Sobhiafshar1, Betül Çakici1, Erdem Yilmaz1

  • 1Department of Molecular Biology and Genetics, Boğaziçi University, Istanbul, Turkey.

Molecular Oncology
|June 16, 2024
PubMed

Insights

Interferon regulatory factor 4 (IRF4) drives melanoma cell dependency and patient mortality. IRF4 targets epigenetic silencers, impacting tumor suppressor genes and oncogenic pathways, suggesting new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Interferon regulatory factor 4 (IRF4) is crucial for lymphocyte function and implicated in cancers.
  • IRF4's role in melanocytes involves pigmentation, but its function in melanoma cells is not well understood.
  • Previous genetic studies suggest IRF4's involvement in melanoma development.

Purpose of the Study:

  • To investigate the function and significance of IRF4 in melanoma cells.
  • To identify novel target genes and pathways regulated by IRF4 in melanoma.
  • To explore the therapeutic potential of targeting IRF4 in melanoma treatment.

Main Methods:

  • Confirmed prevalent IRF4 expression in melanoma tissues.
  • Analyzed genes activated by IRF4, focusing on epigenetic regulators.
  • Investigated IRF4's impact on tumor suppressor gene expression and oncogenic pathways (WNT/β-catenin, AKT).

Main Results:

  • High IRF4 expression in melanoma correlates with cellular dependency and patient mortality.
  • IRF4 activates epigenetic silencing factors like DNMT1, DNMT3B, UHRF1, and EZH2.
  • IRF4 controls expression of tumor suppressors (e.g., CDKN1A, CDKN1B, PTEN) and modulates oncogenic pathways, affecting cell proliferation and survival.

Conclusions:

  • IRF4 is a significant factor in melanoma progression and patient outcomes.
  • IRF4 regulates key epigenetic modifiers and tumor suppressor genes, impacting melanoma cell behavior.
  • Targeting IRF4 may enhance the efficacy of epigenetic therapies in melanoma, warranting further investigation.
Keywords:
DNA methylationIRF4epigenetic silencingepi‐drugshistone methylationmelanoma

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

11.9K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

846

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K